Key result
Planned PUSDY trial evaluates non-inferiority of same-day discharge versus usual care post-urgent PCI for 30-day MACCE.
Why the study?
In overcrowded Chinese hospitals, adoption of same-day discharge after PCI could save healthcare resources and costs, but its feasibility and non-inferiority had not been examined.
Does same-day discharge post-urgent PCI result in non-inferior rates of major adverse cardiovascular and cerebrovascular events compared to usual care in patients with mild to moderate myocardial infarction?
RCT (n=1,296)
Unblinded
1:1 centralised
Yes
Does same-day discharge post-urgent PCI result in non-inferior rates of major adverse cardiovascular and cerebrovascular events compared to usual care in patients with mild to moderate myocardial infarction?
Answers are grounded in this paper and cite their sources.
This trial protocol outlines a non-inferiority study to determine if same-day discharge post-urgent PCI is safe and feasible in the Chinese healthcare system.
INTRODUCTION: In the Chinese healthcare system, where there is overcrowding in hospitals, especially in tertiary care centres, adoption of same-day discharge (SDD) post-percutaneous coronary intervention (PCI) could potentially lead to significant savings of healthcare resources and costs. This study is a non-inferiority trial examining whether post-PCI SDD is feasible in China. The primary hypothesis is that patient outcomes in post-urgent PCI SDD patients are non-inferior to regular discharge patients. METHODS AND ANALYSIS: Post-Urgent PCI Same-DaY is an investigator-initiated multicentre randomised unblinded clinical non-inferiority trial, with 1:1 centralised randomisation to the SDD or usual care (UC) group. Based on sample size calculations, 1296 patients from at least three hospitals, with mild to moderate myocardial infarction, will be included, and acute coronary syndrome patients will be excluded. All patients will receive UC while patients assigned to the SDD group will be discharged on the same day or within 12 hours post-PCI. The primary outcome is major adverse cardiovascular and cerebrovascular events 30 days after discharge. The secondary outcomes are all-cause mortality, bleeding and access site complications. The outcome rates will be compared between groups with the absolute risk difference with a 95% CI. ETHICS AND DISSEMINATION: The study protocol V.2.0 has been approved on 21 January 2022 by the Ethics Committee of Beijing Anzhen Hospital, Capital Medical University (approval number: 2021 KLSD No. 23). The outcomes of this study will be disseminated through a peer-reviewed journal and presented at international conferences. TRIAL REGISTRATION NUMBER: ChiCTR 2200057065; China Clinical Trial Registration.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) conducted an RCT in Mild to moderate myocardial infarction post-urgent PCI (n=1,296). Same-day discharge (SDD) vs. Usual care was evaluated on Major adverse cardiovascular and cerebrovascular events 30 days after discharge. The PUSDY trial is a planned randomized non-inferiority trial of 1296 patients to evaluate whether same-day discharge post-urgent PCI is non-inferior to usual care for 30-day MACCE.
Synapse has enriched 10 related papers. Consider them for comparative context: